Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Sciences, Inc. $GILD Shares Sold by ProShare Advisors LLC
06:42am, Monday, 09'th Feb 2026
ProShare Advisors LLC reduced its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 18.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities an
Candriam S.C.A. Has $179.86 Million Stock Holdings in Gilead Sciences, Inc. $GILD
06:08am, Monday, 09'th Feb 2026
Candriam S.C.A. lifted its stake in Gilead Sciences, Inc. (NASDAQ: GILD) by 7.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The
Oppenheimer & Co. Inc. Sells 4,137 Shares of Gilead Sciences, Inc. $GILD
04:58am, Monday, 09'th Feb 2026
Oppenheimer and Co. Inc. reduced its holdings in Gilead Sciences, Inc. (NASDAQ: GILD) by 1.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commiss
Alps Advisors Inc. Increases Holdings in Gilead Sciences, Inc. $GILD
03:08am, Monday, 09'th Feb 2026
Alps Advisors Inc. boosted its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 171.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and
Wall Street Week Ahead
05:59am, Sunday, 08'th Feb 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Daniel Patrick O’day Sells 115,640 Shares of Gilead Sciences (NASDAQ:GILD) Stock
04:02am, Sunday, 08'th Feb 2026
Gilead Sciences, Inc. (NASDAQ: GILD - Get Free Report) CEO Daniel Patrick O'day sold 115,640 shares of the stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an av
Canada Post Corp Registered Pension Plan Has $11.64 Million Position in Gilead Sciences, Inc. $GILD
04:48am, Saturday, 07'th Feb 2026
Canada Post Corp Registered Pension Plan grew its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 110.4% during the undefined quarter, according to the company in its most recent disclosure with t
a16z Perennial Management L.P. Invests $401,000 in Gilead Sciences, Inc. $GILD
03:24am, Saturday, 07'th Feb 2026
a16z Perennial Management L.P. bought a new stake in Gilead Sciences, Inc. (NASDAQ: GILD) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange
FDA Approves Label Update for Kite's Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
08:30am, Friday, 06'th Feb 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel)
Should You Buy, Hold, or Sell GILD Stock Ahead of Q4 Earnings?
10:16am, Thursday, 05'th Feb 2026
GILD readies Q4 results as HIV drugs Biktarvy and Descovy drive growth, while Yeztugo uptake and cell therapy headwinds shape expectations.
Ahead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:16am, Thursday, 05'th Feb 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Gilead (GILD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
Gilead Sciences, Inc. $GILD Stock Holdings Increased by Jones Financial Companies Lllp
05:44am, Thursday, 05'th Feb 2026
Jones Financial Companies Lllp boosted its stake in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 9.8% during the third quarter, according to its most recent disclosure with the SEC. The instituti
ABN AMRO Bank N.V. Acquires Shares of 46,091 Gilead Sciences, Inc. $GILD
04:58am, Thursday, 05'th Feb 2026
ABN AMRO Bank N.V. acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ: GILD) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchan
Machina Capital S.A.S. Makes New $1.65 Million Investment in Gilead Sciences, Inc. $GILD
04:58am, Thursday, 05'th Feb 2026
Machina Capital S.A.S. acquired a new stake in Gilead Sciences, Inc. (NASDAQ: GILD) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The
Ashton Thomas Private Wealth LLC Acquires 10,107 Shares of Gilead Sciences, Inc. $GILD
04:24am, Thursday, 05'th Feb 2026
Ashton Thomas Private Wealth LLC grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 21.1% during the third quarter, according to its most recent 13F filing with the SEC. The instit
